Try our Advanced Search for more refined results
December 06, 2021
Securities and Exchange Commission v. American Renal Associates Holdings, Inc. et al
Case Number:
1:21-cv-10366
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 06, 2021
SEC Hits Dialysis Co., Execs With Accounting Fraud Claim
The U.S. Securities and Exchange Commission announced a $2 million deal with American Renal Associates Holdings Inc. on Monday along with a complaint that says the company and three former executives manipulated "topside" insurance payment adjustments to hit financial targets.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login